Review




Structured Review

Arraystar inc human m 6 epitranscriptomic microarray
Human M 6 Epitranscriptomic Microarray, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+m+6+a+epitranscriptomic+microarray/human+mrna+lncrna+epitranscriptomic+microarray/pmc11229380-485-14-9
Average 90 stars, based on 1 article reviews
human m 6 epitranscriptomic microarray - by Bioz Stars, 2026-11
90/100 stars

Images

Related Articles

Microarray:

Article Title: N6-methyladenosine regulates metabolic remodeling in kidney aging through transcriptional regulator GLIS1
Article Snippet: .. The RNAs were then hybridized to the Arraystar Human mRNA Epitranscriptomic Microarray (8 × 60 K, Arraystar). ..

Article Title: N6-methyladenosine regulates metabolic remodeling in kidney aging through transcriptional regulator GLIS1
Article Snippet: .. Human m6A epitranscriptomic microarray and mRNA microarray analyses were performed based on Arraystar’s standard protocols. ..

Article Title: METTL3 promotes human amniotic epithelial stem cells differentiation into insulin-producing cells by regulation of MaFA expression.
Article Snippet: Objective: Generating mature β-cells from stem cells remains a significant challenge in diabetes cell therapy.. Human amniotic epithelial stem cells (hAESCs) have made their mark in regenerative medicine, and provide several advantages compared to other stem cells.. Methyltransferase-like 3 (METTL3), an essential RNA methyltransferase participating in N6-methyladenosine (m6A) mRNA methylation, plays a critical role in the normal development of β-cells, yet its deletion in β-cells leads to β-cell dysfunction and hyperglycemia.

Article Title: WTAP/YTHDF1-mediated m 6 A modification amplifies IFN-γ-induced immunosuppressive properties of human MSCs
Article Snippet: .. In the hybridization step, the cRNA was merged to the Arraystar Human m 6 A Epitranscriptomic Microarray (8 × 60 K; Arraystar, Rockville, USA). .. Finally, the array was scanned using an Agilent G2505C scanner.

Article Title: Linking oxysterols and different stages of mild cognitive impairment: insights from gut metabolites and N6-methyladenosine
Article Snippet: The “IP” and “Sup” RNAs were labeled with Cy5 and Cy3 respectively as cRNAs in separate reactions using Arraystar RNA Labeling Protocol. .. The cRNAs were combined and hybridized onto Arraystar Human mRNA Epitranscriptomic Microarray (8 × 60 K, Arraystar). .. After washing the slides, the arrays were scanned in two-color channels by an Agilent Scanner G2505C.

other:

Article Title: Noncoding RNA and Alcohol Use Disorder: A Scoping Review of Current Research and Knowledge Gaps
Article Snippet: Human , M , Brain , miRNeasy mini-Kit , Arraystar m6AmRNA & lncRNA Epitranscriptomic Microarray Assay , 29 mRNAs, five lncRNAs, and three miRNAs were differentially methylated (|FC| ≥ 2 and p < 0.05) in people with AUD. , Liu, 2022 .

Hybridization:

Article Title: METTL3 promotes human amniotic epithelial stem cells differentiation into insulin-producing cells by regulation of MaFA expression.
Article Snippet: Objective: Generating mature β-cells from stem cells remains a significant challenge in diabetes cell therapy.. Human amniotic epithelial stem cells (hAESCs) have made their mark in regenerative medicine, and provide several advantages compared to other stem cells.. Methyltransferase-like 3 (METTL3), an essential RNA methyltransferase participating in N6-methyladenosine (m6A) mRNA methylation, plays a critical role in the normal development of β-cells, yet its deletion in β-cells leads to β-cell dysfunction and hyperglycemia.

Article Title: WTAP/YTHDF1-mediated m 6 A modification amplifies IFN-γ-induced immunosuppressive properties of human MSCs
Article Snippet: .. In the hybridization step, the cRNA was merged to the Arraystar Human m 6 A Epitranscriptomic Microarray (8 × 60 K; Arraystar, Rockville, USA). .. Finally, the array was scanned using an Agilent G2505C scanner.

Methylation:

Article Title: M 6 A -mediated lncRNA SCIRT stability promotes NSCLC progression through binding to SFPQ and activating the PI3K/Akt pathway
Article Snippet: .. In this research, we applied Arraystar m 6 A lncRNA epitranscriptomic microarrays to screen differentially m 6 A-methylated lncRNAs in lung cancer and adjacent tissues and then identified the priority candidate genes SCIRT. m 6 A methylation and SCIRT expression were upregulated in a METTL3-dependent manner in NSCLC cells. ..

Expressing:

Article Title: M 6 A -mediated lncRNA SCIRT stability promotes NSCLC progression through binding to SFPQ and activating the PI3K/Akt pathway
Article Snippet: .. In this research, we applied Arraystar m 6 A lncRNA epitranscriptomic microarrays to screen differentially m 6 A-methylated lncRNAs in lung cancer and adjacent tissues and then identified the priority candidate genes SCIRT. m 6 A methylation and SCIRT expression were upregulated in a METTL3-dependent manner in NSCLC cells. ..



Similar Products

90
Arraystar inc human m 6 a epitranscriptomic microarray
WTAP is required for IFN-γ-licensing immunosuppressive process in hUC-MSCs. (A) log2 (FC) of differential expressed genes of hUC-MSCs with and without IFN-γ (I) treatment (fold change > 2, FDR < 0.05). (B) The correlation of log2 (FC) of differentially expressed transcripts in hUC-MSCs with or without IFN-γ treatment and log2 (FC) of differentially m 6 A modification transcripts in hUC-MSCs with or without IFN-γ treatment are indicated (|log FC| ≥ 1; p-value < 0.05). Group 1 (red) were those transcripts that were upregulated in both RNA-seq and <t>epitranscriptomic</t> <t>microarray;</t> Group 2 (blue) were transcripts that were down-regulated in both groups. (C) Heatmap of representative IFN-γ-licensing immunosuppressive process associated genes by epitranscriptomic microarray. (D) Western blotting analysis of m 6 A writers (METTL3, METTL14, and WTAP) in hUC-MSCs with or without IFN-γ induction. (E) qRT–PCR analysis of the relative mRNA levels of m 6 A writers in hUC-MSCs with or without IFN-γ induction (n = 3). (F) The correlation of log2 (FC) of differentially expressed transcripts in hUC-MSCs with WTAP knockdown (WTAP-KD) and log2 (FC) of differentially m 6 A modification transcripts in hUC-MSCs with WTAP knockdown are indicated (|log FC| ≥ 1; p-value < 0.05). (G) Venn diagram of hypomethylated targets in WTAP-KD hUC-MSCs and hypermethylated-up or hypomethylated-up genes in IFN-γ-licensing hUC-MSCs. Statistical significance was calculated by Student’s t -test. *P < 0.05, **P < 0.01, ***P < 0.001, ns, non-significant. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Human M 6 A Epitranscriptomic Microarray, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+m+6+a+epitranscriptomic+microarray/human+mrna+lncrna+epitranscriptomic+microarray/pmc12126738-65-15-21
Average 90 stars, based on 1 article reviews
human m 6 a epitranscriptomic microarray - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Arraystar inc human m 6 epitranscriptomic microarray
WTAP is required for IFN-γ-licensing immunosuppressive process in hUC-MSCs. (A) log2 (FC) of differential expressed genes of hUC-MSCs with and without IFN-γ (I) treatment (fold change > 2, FDR < 0.05). (B) The correlation of log2 (FC) of differentially expressed transcripts in hUC-MSCs with or without IFN-γ treatment and log2 (FC) of differentially m 6 A modification transcripts in hUC-MSCs with or without IFN-γ treatment are indicated (|log FC| ≥ 1; p-value < 0.05). Group 1 (red) were those transcripts that were upregulated in both RNA-seq and <t>epitranscriptomic</t> <t>microarray;</t> Group 2 (blue) were transcripts that were down-regulated in both groups. (C) Heatmap of representative IFN-γ-licensing immunosuppressive process associated genes by epitranscriptomic microarray. (D) Western blotting analysis of m 6 A writers (METTL3, METTL14, and WTAP) in hUC-MSCs with or without IFN-γ induction. (E) qRT–PCR analysis of the relative mRNA levels of m 6 A writers in hUC-MSCs with or without IFN-γ induction (n = 3). (F) The correlation of log2 (FC) of differentially expressed transcripts in hUC-MSCs with WTAP knockdown (WTAP-KD) and log2 (FC) of differentially m 6 A modification transcripts in hUC-MSCs with WTAP knockdown are indicated (|log FC| ≥ 1; p-value < 0.05). (G) Venn diagram of hypomethylated targets in WTAP-KD hUC-MSCs and hypermethylated-up or hypomethylated-up genes in IFN-γ-licensing hUC-MSCs. Statistical significance was calculated by Student’s t -test. *P < 0.05, **P < 0.01, ***P < 0.001, ns, non-significant. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Human M 6 Epitranscriptomic Microarray, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+m+6+a+epitranscriptomic+microarray/human+mrna+lncrna+epitranscriptomic+microarray/pmc11229380-485-14-9
Average 90 stars, based on 1 article reviews
human m 6 epitranscriptomic microarray - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Arraystar inc human m 6 a-modified lncrna epitranscriptomic microarray
Characteristics of the m 6 A-modified <t>lncRNA</t> <t>microarray</t> in LUAD tumor tissues and adjacent normal tissues. A The source distribution of m 6 A-modified lncRNA transcripts. B The length distribution of m 6 A-modified lncRNA transcripts (≤ 3000 bp). C The chromosomal localization of m 6 A-modified lncRNA transcripts. D Volcano plot showed that in 2846 m 6 A-modified lncRNA transcripts, 143 were differentially modified (|log 2 FC|> 0.585, P < 0.05, unpaired t test), and 123 were hypermethylated and 20 were hypomethylated. E The methylation level heatmap of 143 differentially modified lncRNA transcripts. F Volcano plot showed that in 143 differentially modified lncRNA transcripts, 32 were upregulated and 48 were downregulated (|log 2 FC|> 1, P < 0.05, unpaired t test). G The expression level heatmap of 143 differentially modified lncRNA transcripts
Human M 6 A Modified Lncrna Epitranscriptomic Microarray, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+m+6+a+epitranscriptomic+microarray/human+mrna+lncrna+epitranscriptomic+microarray/pmc10082542-44-7-2
Average 90 stars, based on 1 article reviews
human m 6 a-modified lncrna epitranscriptomic microarray - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Arraystar inc human m 6 a-lncrna epitranscriptomic microarray
Characteristics of the m 6 A-modified <t>lncRNA</t> <t>microarray</t> in LUAD tumor tissues and adjacent normal tissues. A The source distribution of m 6 A-modified lncRNA transcripts. B The length distribution of m 6 A-modified lncRNA transcripts (≤ 3000 bp). C The chromosomal localization of m 6 A-modified lncRNA transcripts. D Volcano plot showed that in 2846 m 6 A-modified lncRNA transcripts, 143 were differentially modified (|log 2 FC|> 0.585, P < 0.05, unpaired t test), and 123 were hypermethylated and 20 were hypomethylated. E The methylation level heatmap of 143 differentially modified lncRNA transcripts. F Volcano plot showed that in 143 differentially modified lncRNA transcripts, 32 were upregulated and 48 were downregulated (|log 2 FC|> 1, P < 0.05, unpaired t test). G The expression level heatmap of 143 differentially modified lncRNA transcripts
Human M 6 A Lncrna Epitranscriptomic Microarray, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+m+6+a+epitranscriptomic+microarray/human+mrna+lncrna+epitranscriptomic+microarray/pmc10082542-259-4-3
Average 90 stars, based on 1 article reviews
human m 6 a-lncrna epitranscriptomic microarray - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Arraystar inc human arraystar m 6 a epitranscriptomic microarray
Characteristics of the m 6 A-modified <t>lncRNA</t> <t>microarray</t> in LUAD tumor tissues and adjacent normal tissues. A The source distribution of m 6 A-modified lncRNA transcripts. B The length distribution of m 6 A-modified lncRNA transcripts (≤ 3000 bp). C The chromosomal localization of m 6 A-modified lncRNA transcripts. D Volcano plot showed that in 2846 m 6 A-modified lncRNA transcripts, 143 were differentially modified (|log 2 FC|> 0.585, P < 0.05, unpaired t test), and 123 were hypermethylated and 20 were hypomethylated. E The methylation level heatmap of 143 differentially modified lncRNA transcripts. F Volcano plot showed that in 143 differentially modified lncRNA transcripts, 32 were upregulated and 48 were downregulated (|log 2 FC|> 1, P < 0.05, unpaired t test). G The expression level heatmap of 143 differentially modified lncRNA transcripts
Human Arraystar M 6 A Epitranscriptomic Microarray, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+m+6+a+epitranscriptomic+microarray/human+mrna+lncrna+epitranscriptomic+microarray/pmc09798116-72-10-11
Average 90 stars, based on 1 article reviews
human arraystar m 6 a epitranscriptomic microarray - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Arraystar inc human m 6 a-mrna&lncrna epitranscriptomic microarray
Characteristics of the m 6 A-modified <t>lncRNA</t> <t>microarray</t> in LUAD tumor tissues and adjacent normal tissues. A The source distribution of m 6 A-modified lncRNA transcripts. B The length distribution of m 6 A-modified lncRNA transcripts (≤ 3000 bp). C The chromosomal localization of m 6 A-modified lncRNA transcripts. D Volcano plot showed that in 2846 m 6 A-modified lncRNA transcripts, 143 were differentially modified (|log 2 FC|> 0.585, P < 0.05, unpaired t test), and 123 were hypermethylated and 20 were hypomethylated. E The methylation level heatmap of 143 differentially modified lncRNA transcripts. F Volcano plot showed that in 143 differentially modified lncRNA transcripts, 32 were upregulated and 48 were downregulated (|log 2 FC|> 1, P < 0.05, unpaired t test). G The expression level heatmap of 143 differentially modified lncRNA transcripts
Human M 6 A Mrna&Lncrna Epitranscriptomic Microarray, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+m+6+a+epitranscriptomic+microarray/human+mrna+lncrna+epitranscriptomic+microarray/pmc09251069-95-2-1
Average 90 stars, based on 1 article reviews
human m 6 a-mrna&lncrna epitranscriptomic microarray - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Arraystar inc human m 6 a-mrna and lncrna epitranscriptomic microarray
The differentially expressed profile of m6A-mRNAs in immature red blood cells of Hb CS thalassemia (T) and healthy volunteers controls (N) (* P < 0.05.). Relative mRNA expression, as evidenced by qRT-PCR. The qRT-PCR data ( A ) was consistent with the <t>epitranscriptomic</t> rnicroarray sequence ( B ).
Human M 6 A Mrna And Lncrna Epitranscriptomic Microarray, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+m+6+a+epitranscriptomic+microarray/human+mrna+lncrna+epitranscriptomic+microarray/pmc08516988-177-9-3
Average 90 stars, based on 1 article reviews
human m 6 a-mrna and lncrna epitranscriptomic microarray - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


WTAP is required for IFN-γ-licensing immunosuppressive process in hUC-MSCs. (A) log2 (FC) of differential expressed genes of hUC-MSCs with and without IFN-γ (I) treatment (fold change > 2, FDR < 0.05). (B) The correlation of log2 (FC) of differentially expressed transcripts in hUC-MSCs with or without IFN-γ treatment and log2 (FC) of differentially m 6 A modification transcripts in hUC-MSCs with or without IFN-γ treatment are indicated (|log FC| ≥ 1; p-value < 0.05). Group 1 (red) were those transcripts that were upregulated in both RNA-seq and epitranscriptomic microarray; Group 2 (blue) were transcripts that were down-regulated in both groups. (C) Heatmap of representative IFN-γ-licensing immunosuppressive process associated genes by epitranscriptomic microarray. (D) Western blotting analysis of m 6 A writers (METTL3, METTL14, and WTAP) in hUC-MSCs with or without IFN-γ induction. (E) qRT–PCR analysis of the relative mRNA levels of m 6 A writers in hUC-MSCs with or without IFN-γ induction (n = 3). (F) The correlation of log2 (FC) of differentially expressed transcripts in hUC-MSCs with WTAP knockdown (WTAP-KD) and log2 (FC) of differentially m 6 A modification transcripts in hUC-MSCs with WTAP knockdown are indicated (|log FC| ≥ 1; p-value < 0.05). (G) Venn diagram of hypomethylated targets in WTAP-KD hUC-MSCs and hypermethylated-up or hypomethylated-up genes in IFN-γ-licensing hUC-MSCs. Statistical significance was calculated by Student’s t -test. *P < 0.05, **P < 0.01, ***P < 0.001, ns, non-significant. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

Journal: Journal of Advanced Research

Article Title: WTAP/YTHDF1-mediated m 6 A modification amplifies IFN-γ-induced immunosuppressive properties of human MSCs

doi: 10.1016/j.jare.2024.06.019

Figure Lengend Snippet: WTAP is required for IFN-γ-licensing immunosuppressive process in hUC-MSCs. (A) log2 (FC) of differential expressed genes of hUC-MSCs with and without IFN-γ (I) treatment (fold change > 2, FDR < 0.05). (B) The correlation of log2 (FC) of differentially expressed transcripts in hUC-MSCs with or without IFN-γ treatment and log2 (FC) of differentially m 6 A modification transcripts in hUC-MSCs with or without IFN-γ treatment are indicated (|log FC| ≥ 1; p-value < 0.05). Group 1 (red) were those transcripts that were upregulated in both RNA-seq and epitranscriptomic microarray; Group 2 (blue) were transcripts that were down-regulated in both groups. (C) Heatmap of representative IFN-γ-licensing immunosuppressive process associated genes by epitranscriptomic microarray. (D) Western blotting analysis of m 6 A writers (METTL3, METTL14, and WTAP) in hUC-MSCs with or without IFN-γ induction. (E) qRT–PCR analysis of the relative mRNA levels of m 6 A writers in hUC-MSCs with or without IFN-γ induction (n = 3). (F) The correlation of log2 (FC) of differentially expressed transcripts in hUC-MSCs with WTAP knockdown (WTAP-KD) and log2 (FC) of differentially m 6 A modification transcripts in hUC-MSCs with WTAP knockdown are indicated (|log FC| ≥ 1; p-value < 0.05). (G) Venn diagram of hypomethylated targets in WTAP-KD hUC-MSCs and hypermethylated-up or hypomethylated-up genes in IFN-γ-licensing hUC-MSCs. Statistical significance was calculated by Student’s t -test. *P < 0.05, **P < 0.01, ***P < 0.001, ns, non-significant. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

Article Snippet: In the hybridization step, the cRNA was merged to the Arraystar Human m 6 A Epitranscriptomic Microarray (8 × 60 K; Arraystar, Rockville, USA).

Techniques: Modification, RNA Sequencing, Microarray, Western Blot, Quantitative RT-PCR, Knockdown

Characteristics of the m 6 A-modified lncRNA microarray in LUAD tumor tissues and adjacent normal tissues. A The source distribution of m 6 A-modified lncRNA transcripts. B The length distribution of m 6 A-modified lncRNA transcripts (≤ 3000 bp). C The chromosomal localization of m 6 A-modified lncRNA transcripts. D Volcano plot showed that in 2846 m 6 A-modified lncRNA transcripts, 143 were differentially modified (|log 2 FC|> 0.585, P < 0.05, unpaired t test), and 123 were hypermethylated and 20 were hypomethylated. E The methylation level heatmap of 143 differentially modified lncRNA transcripts. F Volcano plot showed that in 143 differentially modified lncRNA transcripts, 32 were upregulated and 48 were downregulated (|log 2 FC|> 1, P < 0.05, unpaired t test). G The expression level heatmap of 143 differentially modified lncRNA transcripts

Journal: Clinical Epigenetics

Article Title: Comprehensive analyses of molecular features, prognostic values, and regulatory functionalities of m 6 A-modified long non-coding RNAs in lung adenocarcinoma

doi: 10.1186/s13148-023-01475-z

Figure Lengend Snippet: Characteristics of the m 6 A-modified lncRNA microarray in LUAD tumor tissues and adjacent normal tissues. A The source distribution of m 6 A-modified lncRNA transcripts. B The length distribution of m 6 A-modified lncRNA transcripts (≤ 3000 bp). C The chromosomal localization of m 6 A-modified lncRNA transcripts. D Volcano plot showed that in 2846 m 6 A-modified lncRNA transcripts, 143 were differentially modified (|log 2 FC|> 0.585, P < 0.05, unpaired t test), and 123 were hypermethylated and 20 were hypomethylated. E The methylation level heatmap of 143 differentially modified lncRNA transcripts. F Volcano plot showed that in 143 differentially modified lncRNA transcripts, 32 were upregulated and 48 were downregulated (|log 2 FC|> 1, P < 0.05, unpaired t test). G The expression level heatmap of 143 differentially modified lncRNA transcripts

Article Snippet: Importantly, the Arraystar Human M 6 A-modified LncRNA Epitranscriptomic Microarray was utilized to analyze the characteristics of m 6 A-modified lncRNAs and screen out lncRNAs with differential methylation level in LUAD.

Techniques: Modification, Microarray, Methylation, Expressing

Combined analyses of m 6 A modification and expression profiles of 143 differentially m 6 A-modified lncRNA transcripts in LUAD tissues. A The UpSet diagram was used to divide lncRNAs into six categories. B Spearman correlation analyses between the expression levels and methylation levels of 143 lncRNA transcripts in normal tissues (left), tumor tissues (middle), and all tissues (right). A point’s horizontal and vertical coordinates were the mean m 6 A level and mean expression level of a lncRNA transcript in six normal tissues (left), four tumor tissues (middle), and all ten tissues (right), respectively. C Validation of four lncRNAs’ expression levels in six pairs of clinical tissues; GAPDH served as the reference gene. * P < 0.05 and not significant (ns) P > 0.05. Paired t test. D Validation of four lncRNAs’ m 6 A levels in six pairs of clinical tissues by MeRIP-qPCR assays; Input was used as the reference. * P < 0.05, ** P < 0.01 and *** P < 0.001. Paired t test

Journal: Clinical Epigenetics

Article Title: Comprehensive analyses of molecular features, prognostic values, and regulatory functionalities of m 6 A-modified long non-coding RNAs in lung adenocarcinoma

doi: 10.1186/s13148-023-01475-z

Figure Lengend Snippet: Combined analyses of m 6 A modification and expression profiles of 143 differentially m 6 A-modified lncRNA transcripts in LUAD tissues. A The UpSet diagram was used to divide lncRNAs into six categories. B Spearman correlation analyses between the expression levels and methylation levels of 143 lncRNA transcripts in normal tissues (left), tumor tissues (middle), and all tissues (right). A point’s horizontal and vertical coordinates were the mean m 6 A level and mean expression level of a lncRNA transcript in six normal tissues (left), four tumor tissues (middle), and all ten tissues (right), respectively. C Validation of four lncRNAs’ expression levels in six pairs of clinical tissues; GAPDH served as the reference gene. * P < 0.05 and not significant (ns) P > 0.05. Paired t test. D Validation of four lncRNAs’ m 6 A levels in six pairs of clinical tissues by MeRIP-qPCR assays; Input was used as the reference. * P < 0.05, ** P < 0.01 and *** P < 0.001. Paired t test

Article Snippet: Importantly, the Arraystar Human M 6 A-modified LncRNA Epitranscriptomic Microarray was utilized to analyze the characteristics of m 6 A-modified lncRNAs and screen out lncRNAs with differential methylation level in LUAD.

Techniques: Modification, Expressing, Methylation, Biomarker Discovery

The screening of prognostic m 6 A-regulated lncRNAs. A The screening criteria of 215 m 6 A-regulated lncRNAs and its expression correlation with m 6 A regulators. B Forest plot of univariate Cox regression analysis of m 6 A-regulated lncRNAs ( P < 0.01). The hazard ratio (HR) value, its 95% confidence interval (CI), as well as the associated P value, were shown. HR > 1 indicated that the lncRNA was a risk factor and its high expression was unfavorable for prognosis, while the high expression of the protective lncRNA of HR < 1 was favorable for prognosis. C The expression correlation between 13 prognostic m 6 A-regulated lncRNAs and m 6 A regulators

Journal: Clinical Epigenetics

Article Title: Comprehensive analyses of molecular features, prognostic values, and regulatory functionalities of m 6 A-modified long non-coding RNAs in lung adenocarcinoma

doi: 10.1186/s13148-023-01475-z

Figure Lengend Snippet: The screening of prognostic m 6 A-regulated lncRNAs. A The screening criteria of 215 m 6 A-regulated lncRNAs and its expression correlation with m 6 A regulators. B Forest plot of univariate Cox regression analysis of m 6 A-regulated lncRNAs ( P < 0.01). The hazard ratio (HR) value, its 95% confidence interval (CI), as well as the associated P value, were shown. HR > 1 indicated that the lncRNA was a risk factor and its high expression was unfavorable for prognosis, while the high expression of the protective lncRNA of HR < 1 was favorable for prognosis. C The expression correlation between 13 prognostic m 6 A-regulated lncRNAs and m 6 A regulators

Article Snippet: Importantly, the Arraystar Human M 6 A-modified LncRNA Epitranscriptomic Microarray was utilized to analyze the characteristics of m 6 A-modified lncRNAs and screen out lncRNAs with differential methylation level in LUAD.

Techniques: Expressing

Construction of m 6 A-induced ceRNA Network. A The subcellular localization of 43 differentially m 6 A-modified lncRNAs according to RNALoate. B The construction process of the ceRNA network, which consisted of 11 correlative m 6 A regulators, seven differentially modified lncRNAs, 30 sponged miRNAs, and 110 targeted mRNAs. C The diagram of the ceRNA network. The lines connecting m 6 A regulators and lncRNAs represented RNA co-expression in TCGA-LUAD set (| r |> 0.3 and P < 0.001), and the red line represented the lncRNA-m 6 A regulator protein combination detected by CLIP-seq recorded in the POSTAR3 database. D The chart emphasized the dysregulated targeted mRNAs in LUAD, whose numbers of connecting nodes were greater than or equal to 3 in the ceRNA network. FC represented the expression fold change of T-median/N-median. WilcoxTest. *** P < 0.001

Journal: Clinical Epigenetics

Article Title: Comprehensive analyses of molecular features, prognostic values, and regulatory functionalities of m 6 A-modified long non-coding RNAs in lung adenocarcinoma

doi: 10.1186/s13148-023-01475-z

Figure Lengend Snippet: Construction of m 6 A-induced ceRNA Network. A The subcellular localization of 43 differentially m 6 A-modified lncRNAs according to RNALoate. B The construction process of the ceRNA network, which consisted of 11 correlative m 6 A regulators, seven differentially modified lncRNAs, 30 sponged miRNAs, and 110 targeted mRNAs. C The diagram of the ceRNA network. The lines connecting m 6 A regulators and lncRNAs represented RNA co-expression in TCGA-LUAD set (| r |> 0.3 and P < 0.001), and the red line represented the lncRNA-m 6 A regulator protein combination detected by CLIP-seq recorded in the POSTAR3 database. D The chart emphasized the dysregulated targeted mRNAs in LUAD, whose numbers of connecting nodes were greater than or equal to 3 in the ceRNA network. FC represented the expression fold change of T-median/N-median. WilcoxTest. *** P < 0.001

Article Snippet: Importantly, the Arraystar Human M 6 A-modified LncRNA Epitranscriptomic Microarray was utilized to analyze the characteristics of m 6 A-modified lncRNAs and screen out lncRNAs with differential methylation level in LUAD.

Techniques: Modification, Expressing

The differentially expressed profile of m6A-mRNAs in immature red blood cells of Hb CS thalassemia (T) and healthy volunteers controls (N) (* P < 0.05.). Relative mRNA expression, as evidenced by qRT-PCR. The qRT-PCR data ( A ) was consistent with the epitranscriptomic rnicroarray sequence ( B ).

Journal: Scientific Reports

Article Title: Human m 6 A-mRNA and lncRNA epitranscriptomic microarray reveal function of RNA methylation in hemoglobin H-constant spring disease

doi: 10.1038/s41598-021-99867-9

Figure Lengend Snippet: The differentially expressed profile of m6A-mRNAs in immature red blood cells of Hb CS thalassemia (T) and healthy volunteers controls (N) (* P < 0.05.). Relative mRNA expression, as evidenced by qRT-PCR. The qRT-PCR data ( A ) was consistent with the epitranscriptomic rnicroarray sequence ( B ).

Article Snippet: We conducted the Arraystar Human m 6 A-mRNA and lncRNA epitranscriptomic microarray analysis of 5 pairs of immature erythrocytes, particularly, 5 from HbH-CS thalassemia (T) and 5 from healthy volunteers (N).

Techniques: Expressing, Quantitative RT-PCR, Sequencing

The 20 differentially hypo-methylated m6A other RNAS including  lncRNA  and other small RNAs.

Journal: Scientific Reports

Article Title: Human m 6 A-mRNA and lncRNA epitranscriptomic microarray reveal function of RNA methylation in hemoglobin H-constant spring disease

doi: 10.1038/s41598-021-99867-9

Figure Lengend Snippet: The 20 differentially hypo-methylated m6A other RNAS including lncRNA and other small RNAs.

Article Snippet: We conducted the Arraystar Human m 6 A-mRNA and lncRNA epitranscriptomic microarray analysis of 5 pairs of immature erythrocytes, particularly, 5 from HbH-CS thalassemia (T) and 5 from healthy volunteers (N).

Techniques: